<div id="subtitle">Vical says US approves Oncept dog vaccine, which will be marketed by Sanofi-Aventis</div><div><p>Drug developer Vical Inc. said Monday the Agriculture Department approved Oncept, a vaccine intended to treat oral melanoma in dogs.</p><p>Vical developed the drug and licensed it ...

<div id="subtitle">Vical shares rise after the company says it will be listed on Nasdaq biotech index Nov. 23</div><div><p>Shares of Vical Inc. rose Monday after the company said it shares will be added to Nasdaq Biotechnology Index in a week.</p><p>Vical ...

<div id="subtitle">Vical says its developing swine flu vaccine prompts immune responses in mice, rabbits</div><div><p>Biotechnology company Vical Inc. said Thursday its developing swine flu vaccine prompted "robust" immune responses in 100 percent of animals infected with distinct strains of the virus.</p><p&gt ...

<div><p>Biopharmaceuticals company Vical Inc. said Tuesday that animal tests of a potential swine flu vaccine were successful.</p><p>In the preclinical tests, Vical said all mice and rabbits who were injected with the vaccine were protected from the flu virus. It said 75 percent of the animals reached or ...